Pinnacle Financial Partners (Tennessee)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Pinnacle Financial Partners (Tennessee)'s NVO Position: Q3 2025 in Review
Pinnacle Financial Partners (Tennessee) increased its Novo Nordisk (NVO) stake by 3.6% in Q3 2025, buying an estimated $40.6K and bringing the position to 19,721 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #260.
Pinnacle Financial Partners (Tennessee) first reported a position in NVO in Q2 2013 and has held it in 11 quarters since. The position peaked at $8.9M in Q2 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Pinnacle Financial Partners (Tennessee) held 19,721 shares of Novo Nordisk worth $1.09M as of Q3 2025.
- Pinnacle Financial Partners (Tennessee) bought 694 Novo Nordisk shares in Q3 2025, an estimated $40.6K.
- Novo Nordisk made up 0.03% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #260 holding.
- Pinnacle Financial Partners (Tennessee) first reported a position in Novo Nordisk in Q2 2013 and has held it in 11 quarters since.
- Pinnacle Financial Partners (Tennessee)'s Novo Nordisk position peaked at $8.9M in Q2 2024.
- 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.